BMS 907351,
BMS-907351,
BMS907351,
cabozantinib,
Cometriq,
XL 184,
XL-184,
XL184 cpd,
Cabozantinib,
849217-68-1,
XL184,
Cometriq,
BMS-907351,
XL 184,
XL-184,
BMS 907351,
Cabozantinib (XL184, BMS-907351),
UNII-1C39JW444G,
CHEBI:72317,
BMS907351,
1C39JW444G,
Cometriq (TN),
Cabozantinib (XL-184),
C28H24FN3O5,
1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-,
N'-[4-[(6,7-DIMETHOXY-4-QUINOLINYL)OXY]PHENYL]-N-(4-FLUOROPHENYL)-1,1-CYCLOPROPANEDICARBOXAMIDE,
n-(4-((6,7-dimethoxy-4-quinolinyl)oxy)phenyl)-n'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide,
N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide,
Cabozantinib [USAN:INN],
Cabometyx (TN),
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide,
XL184 free base,
Cabozantinib/XL184,
Cabozantinib (USAN),
Cabozantinib XL-184,
PubChem22994,
cc-10,
1,1-Cyclopropanedicarboxamide, N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-,
SCHEMBL360795,
GTPL5887,
CHEMBL2105717,
DTXSID10233968,
EX-A075,
QCR-122,
SYN1138,
XL184 free base - Cabozantinib,
ONIQOQHATWINJY-UHFFFAOYSA-N,
BCPP000308,
HMS3654G06,
XL-184 free base (Cabozantinib),
AOB87755,
BCP02591,
ABP000796,
BDBM50021574,
MFCD20926324,
s1119,
ZINC70466416,
AKOS025142112,
BCP9000470,
CS-0278,
DB08875,
RL05229,
SB20062,
XL-184 (Cabozantinib BMS907351),
XL-184,Cabozantinib, BMS-907351,
NCGC00263164-01,
NCGC00263164-14,
AC-25082,
AS-16277,
BC267213,
HY-13016,
SC-85393,
AB0033751,
DB-023624,
FT-0664184,
SW218093-3,
X7477,
D10062,
Q-3907,
AB01565831_02,
SR-01000941569,
J-523016,
SR-01000941569-1,
BRD-K51544265-001-01-8,
N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-f,
XL 184, XL-184, 1021950-26-4,
1,1-Cyclopropanedicarboxamide, N'-(4-((6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- fluorophenyl)-,
cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide(4-fluoro-phenyl)-amide,
cyclopropane-1,1-dicarboxylic acid[4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide,
N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4 fluorophenyl)cyclopropane-1,1-dicarboxamide,
N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide,
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide,
N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1- dicarboxamide,
Cabometyx,
Cabozantinib malate,
Cabozantinib S-malate,
Cabozantinib [USAN],
Cabozantinib, XL184,
cabozantinib (S)-malate,
XL184 cpd,
D0IQ6P,
ACN-031542,
A2977,
A10996,
C558660,
N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide,
1021950-26-4,
1140909-48-3,
Cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide,
N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide,